Table 8 Regression analysis for prediction of post-vaccine COVID-19 infection (N = 70) among all vaccinated participants (N = 369)
From: Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
|  | Odd’s ratio | 95% CI | P value |
|---|---|---|---|
Age | 1.02 | 0.99–1.05 | 0.06 |
Marital state (married) | 0.93 | 0.41–2.09 | 0.07 |
Occupation (employee) | 3.14 | 1.62–6.08 | 0.06 |
Hypertension | 3.84 | 0.98–15.03 | 0.66 |
Diabetes mellitus | 1.45 | 0.26–7.92 | 0.99 |
Cardiac diseases | 0.98 | 0.34–2.09 | 0.34 |
Prior infection | 3.54 | 1.89–6.67 | 0.01 |
Type of vaccine (AstraZeneca) | 2.13 | 1.14–3.99 | 0.01 |
Partially vaccinated | 2.56 | 1.16–5.62 |  < 0.001 |